AIRLINK 80.60 Increased By ▲ 1.19 (1.5%)
BOP 5.26 Decreased By ▼ -0.07 (-1.31%)
CNERGY 4.52 Increased By ▲ 0.14 (3.2%)
DFML 34.50 Increased By ▲ 1.31 (3.95%)
DGKC 78.90 Increased By ▲ 2.03 (2.64%)
FCCL 20.85 Increased By ▲ 0.32 (1.56%)
FFBL 33.78 Increased By ▲ 2.38 (7.58%)
FFL 9.70 Decreased By ▼ -0.15 (-1.52%)
GGL 10.11 Decreased By ▼ -0.14 (-1.37%)
HBL 117.85 Decreased By ▼ -0.08 (-0.07%)
HUBC 137.80 Increased By ▲ 3.70 (2.76%)
HUMNL 7.05 Increased By ▲ 0.05 (0.71%)
KEL 4.59 Decreased By ▼ -0.08 (-1.71%)
KOSM 4.56 Decreased By ▼ -0.18 (-3.8%)
MLCF 37.80 Increased By ▲ 0.36 (0.96%)
OGDC 137.20 Increased By ▲ 0.50 (0.37%)
PAEL 22.80 Decreased By ▼ -0.35 (-1.51%)
PIAA 26.57 Increased By ▲ 0.02 (0.08%)
PIBTL 6.76 Decreased By ▼ -0.24 (-3.43%)
PPL 114.30 Increased By ▲ 0.55 (0.48%)
PRL 27.33 Decreased By ▼ -0.19 (-0.69%)
PTC 14.59 Decreased By ▼ -0.16 (-1.08%)
SEARL 57.00 Decreased By ▼ -0.20 (-0.35%)
SNGP 66.75 Decreased By ▼ -0.75 (-1.11%)
SSGC 11.00 Decreased By ▼ -0.09 (-0.81%)
TELE 9.11 Decreased By ▼ -0.12 (-1.3%)
TPLP 11.46 Decreased By ▼ -0.10 (-0.87%)
TRG 70.23 Decreased By ▼ -1.87 (-2.59%)
UNITY 25.20 Increased By ▲ 0.38 (1.53%)
WTL 1.33 Decreased By ▼ -0.07 (-5%)
BR100 7,626 Increased By 100.3 (1.33%)
BR30 24,814 Increased By 164.5 (0.67%)
KSE100 72,743 Increased By 771.4 (1.07%)
KSE30 24,034 Increased By 284.8 (1.2%)

chavezCARACAS: Venezuelan President Hugo Chavez is doing well as he receives medical treatment in Cuba, Vice President Nicolas Maduro said on Thursday, despite a two-week absence from public view that has raised fresh doubts about his health.

 

Chavez, 58, said in a letter to parliament on Tuesday he was returning to Havana for "hyperbaric oxygenation," which is used to treat bone decay caused by radiation therapy. The president has undergone three cancer operations in Cuba since mid-2011.

 

No images were published of his departure from Caracas, nor his arrival on the Communist-led island, fueling speculation among many Venezuelans on whether the latest twist was normal post-radiation treatment, or a more serious downturn.

 

"They are carrying out therapies to strengthen his health even more. The president is good, he is very good, and he is going to get much better," Maduro told a meeting with workers that was broadcast live by Venezuelan state TV.

 

The usually garrulous socialist leader has made few public appearances since winning a new six-year term in an election in October. His campaign was more subdued than usual, and he said afterward that radiation therapy had left him exhausted.

 

Chavez has open-ended authorization from legislators to travel, but aims to be back at least for the Jan. 10 start of his new term, if not for a couple of regional summits before.

 

His latest absence has put renewed attention on Maduro, his vice president, and on Congress head Diosdado Cabello, as two close and powerful allies of the president who might look to replace him if Chavez were to leave power.

 

Under the South American country's constitution, an election would have to be held if Chavez were to leave office within the first four years of his next six-year term.

 

In his televised comments, Maduro called on all Venezuelans to "respect" Chavez as he received treatment, and said voters on the campaign trail had urged the president to focus on his health.

 

"In every town, they told him: 'Take care of yourself president, be disciplined with your treatment.' And that is exactly what he's doing now: fulfilling the people's mandate."

 

Chavez's return to Cuba could be a blow to ruling Socialist Party candidates who wanted to campaign alongside him ahead of state elections on Dec. 16. A prolonged absence could also postpone major policy decisions, such as a widely expected devaluation of the bolivar currency.

 

Given investor hopes for a more market-friendly government in the continent's top oil exporter, Venezuela's widely traded bonds rose for a third straight day on Thursday.

 

The benchmark Global 27 bond and state oil company PDVSA's closely watched 2022 bond were both at year-high prices of 93.98 and 112.25 respectively.

 

Copyright Reuters, 2012

Comments

Comments are closed.